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Perspective  
Older and middle-aged adults demonstrated reduced offset analgesia compared 
to younger adults.  The significant association between reduced offset analgesia and 
pain in daily life supports the notion that pain modulatory deficits are associated with not 
just a chronic pain condition but with the experience of pain in general.   
 
Highlights 
 Older adults demonstrated reduced offset analgesia compared to younger 
adults  
 No sex differences in offset analgesia were evident in any age group 
 A reduction stimuli as small as 0.4oC resulted in significant offset analgesia 
 Reduced offset analgesia was associated with pain in daily life for all age 
groups 
 
Abstract 
An age-related decline in endogenous pain inhibitory processes likely places 
older adults at an increased risk for chronic pain.  Limited research indicates that older 
adults may be characterized by deficient offset analgesia, an inhibitory temporal 
sharpening mechanism that increases the detectability of minor decreases in noxious 
stimulus intensity.  The primary purpose of the study was to examine age differences in 
offset analgesia in community-dwelling younger, middle-aged, and older adults.  An 
additional aim of the study was to determine whether the magnitude of offset analgesia 
predicted self-reported bodily pain.  Eighty-seven younger adults, 42 middle-aged 
adults, and 60 older adults completed 4 offset analgesia trials and 3 constant 
temperature trials in which a noxious heat stimulus was applied to the volar forearm for 
40-sec.  The offset trials consisted of three continuous phases: an initial 10-sec painful 
stimulus (S1), either a 1.0oC or 0.4oC increase in temperature from S1 for 10-sec (S2), 
and either a 1.0oC or 0.4oC decrease back to the initial testing temperature for 20-sec 
(S3).  During each trial, subjects rated pain intensity continuously using an electronic 
visual analogue scale (0-100).  All subjects also completed the SF-36 Health Survey 
including the Bodily Pain subscale.  The results indicated that older and middle-aged 
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adults demonstrated reduced offset analgesia compared to younger adults in the 1.0oC 
and 0.4oC offset trials.  Furthermore, the magnitude of offset analgesia predicted self-
reported bodily pain, with those exhibiting reduced offset analgesia reporting greater 
bodily pain.  Dysfunction of this endogenous inhibitory system could increase the risk of 
developing chronic pain for middle-aged and older adults. 
 
 
1.0 INTRODUCTION 
 Epidemiological studies indicate that the prevalence of chronic pain increases 
with age up to the seventh decade of life with rates reaching as high as 60-75% and 
then plateauing.8,12,37  While multiple mechanisms likely contribute, an age-related 
decline in endogenous pain modulatory processes is likely one mechanism placing 
older adults at an increased risk for the development of persistent pain compared to 
younger adults.  Indeed, older adults exhibit diminished descending pain inhibitory 
capacity15,20,31 and increased pain facilitation likely caused by a sensitized central pain 
system.7,16,21 An imbalance of these systems likely underlies the increased transition 
from acute to chronic pain associated with aging.33 
The majority of evidence indicating that older adults exhibit a diminished pain 
inhibitory capacity compared to younger adults has relied on assessment of pain 
inhibition with the condition pain modulation (CPM) paradigm.15,31  CPM is a dynamic 
quantitative sensory test that represents the behavioral correlate to diffuse noxious 
inhibitory controls, an inhibitory mechanism involving the spinal-bulbo-spinal loop.41 In 
this paradigm, a painful stimulus applied to a remote body site inhibits the experience of 
pain of another noxious stimulus applied to a different body site.  A large body of 
research shows that reduced pain inhibition on the CPM test is a characteristic of many 
chronic pain conditions and represents a predisposition for chronic pain.18,40   
Recently, another dynamic quantitative sensory test, termed offset analgesia, 
has gained attention as another assessment tool for endogenous pain inhibition in pain 
research.13  While CPM represents a spatial filtering mechanism, offset analgesia 
represents an inhibitory temporal sharpening mechanism that increases the detectability 
of small decreases in noxious stimulus intensity.10  Specifically, offset analgesia refers 
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to a pronounced reduction in perceived pain intensity evoked by a small decrease in 
noxious temperature that is disproportionately large compared to the actual decrease in 
temperature.10  Functional imaging and pharmacological studies indicate that CPM and 
offset analgesia rely on different mechanisms, with offset analgesia likely reflecting 
more brain derived pain modulation compared to descending spinal modulatory effects 
of CPM.6,19,22,42 While less is known regarding the relevance of offset analgesia to the 
development of chronic pain, recent but limited evidence suggests that aging is also 
associated with reduced capacity to activate the temporal inhibitory mechanisms 
underlying this phenomenon.20  
The primary purpose of this study was to further explore age-related differences 
in offset analgesia in a large sample of adults.  We recently showed in a smaller study 
that older adults experience reduced offset analgesia compared to younger adults.20  
The current study aimed to extend these findings in several ways.  First, the age at 
which pain modulatory processes begin to decline is not well known, as most pain and 
aging studies have ignored the middle-age group. Importantly, a study by Lariviere and 
colleagues discovered that CPM begins to decline in middle age (40-55 years old).15  
Thus, the primary aim of this study was to evaluate offset analgesia in young, middle-
aged, and older adults.  Secondly, some research indicates that age differences in pain 
may differ between sexes2,17,30; however, limited research has investigated or been 
sufficiently powered to detect sex by age interactions in pain inhibitory processes.  
Therefore, a second aim of this study was to evaluate whether age differences in offset 
analgesia differed as a function of sex.  Third, previous offset studies have shown a 
disproportionate decrease in pain ratings following a 1, 2, or 3oC decrease in 
temperature.10  In addition to the most commonly used 1oC temperature decrease in 
offset trials, the current study assessed whether a temperature decrease of only 0.4oC 
could also evoke offset analgesia. Finally, while studies have shown that offset 
analgesia is reduced in neuropathic pain conditions and fibromyalgia23,24,27, whether the 
magnitude of offset is related to the experience of clinical pain in a community-based 
sample has not been determined.  Thus, the current cross-sectional study examined 
whether the magnitude of offset analgesia predicted self-reported bodily pain in adults. 
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2.0 METHODS 
 
2.1 Participants 
  Participants included 189 community-dwelling adults stratified into 3 age cohorts: 
87 younger adults (Age: M=25.4, SD=5.7, age range: 18-39 years; 47 females and 40 
males), 42 middle-aged adults (Age: M=50.8, SD=5.2, age range: 40-59 years; 23 
females and 19 males), and 60 older adults (Age: M=68.1, SD=5.1, age range: 60-80 
years; 29 females and 31 males).  The overall sample consisted of 108 Caucasians 
(57%), 27 African Americans (14%), 24 Hispanics (13%), 16 Asians (8%) and 14 that 
endorsed mixed-race (7%) and were similarly distributed across the three age cohorts.  
The sample was recruited as part of a larger study examining age-related changes in pain 
inhibitory and facilitatory function (Study of The Effects of Aging on Experimental Models 
of Pain Inhibition and Facilitation).  Recruitment and study procedures were approved by 
the University of Florida Institutional Review Board. Written informed consent was 
obtained from all participants, who were identified only by numbers.  
  Study exclusion criteria included a Mini Mental Status score below 23, current use 
of narcotics or chronic use of analgesics, uncontrolled hypertension, systemic disease 
that restricts normal daily activities, neurological problems with significant changes in 
somatosensory and pain perception at the intended stimulation sites, and serious 
psychiatric conditions (e.g., diagnosis of schizophrenia and bipolar disorder).  Participants 
were asked to refrain from the use of any pain medication or coffee on the day of testing. 
 
2.2 Apparatus 
Testing was performed on a Thermo-Electric Stimulation System 
(Neuroanalytics, Gainesville FL).  Thermal stimuli were administered by a thermode 
(Peltier thermoelectric device) housed in a free standing stimulation module that was 
adjustable from 20-28 inches in height.  At rest, the 40x40 mm thermode is recessed 
behind a cutout in a thermally neutral plastic surface, out of contact with the skin, which 
rests on the plastic surface.  The thermode is brought into reproducible light skin contact 
by a solenoid-powered mechanism with temperature and thermode position controlled 
by a computer.   
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Experimental pain was measured with an electronic visual analog scale (eVAS).  
The eVAS consisted of a low-friction sliding potentiometer of 100 mm travel.  The left 
endpoint of the scale was identified as "no pain", while the right endpoint was defined as 
"intolerable pain".  There were nine hash marks between these two anchors.  The 
position of the slider was electronically converted into a pain rating between 0 and 100.  
The slider automatically returned to the left (“no pain”) position when so required by the 
protocol.  The eVAS was mounted into the surface of a small inclined desk positioned to 
facilitate precise operation with minimal fatigue. The experimental set-up allows the 
participant to be separated from the investigator and facing away to minimize non-
verbal communication and transmission of bias.  
 
2.3 Study procedures 
All subjects were tested in the Pain Clinical Research Unit of the University of 
Florida Pain Research and Intervention Center of Excellence. 
2.3.1 Orientation and training session 
 Individuals who were interested in the study were provided information about the 
procedures, informed about privacy regulations and reviewed and signed an Informed 
Consent Form.  Eligibility for the study was determined after participants completed a 
health history questionnaire, supplemented by interview and a blood pressure 
measurement.  As part of this orientation participants watched a PowerPoint 
presentation with imbedded video and audio overlay that described using a 0-100 pain 
scale.  Participants then received practice with the pain testing stimuli using several 
temperatures.  Once oriented to the stimuli and rating pain, several series of ascending 
heat stimuli trials (+0.5oC per trial with starting temperature of 43oC) were administered 
at the palm with contact time of 5-sec and inter-stimulus intervals of 8-sec.  Each series 
was terminated when ratings surpassed 50.  The temperature at which participants 
rated closest to 40 was then administered to the forearm for 20-sec.  If the 20-sec trial 
failed to reach a pain rating of 35, the next trial was administered at +0.5oC, if the pain 
rating surpassed 50 the next trial preceded at -0.5oC, if the pain rating peaked between 
35-50, that temperature was repeated for the second trial.  A third trial was performed 
with additional temperature adjustment if needed.  The final (baseline) temperature was 
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recorded and administered for a 40-sec trial at the forearm followed by an offset trial 
(10-sec baseline temperature, 10-sec at baseline +1.0oC, and returning to the baseline 
temperature for 20-sec.  This allowed the use of a temperature during the subsequent 
testing session at which a participant would experience at least moderate pain during a 
40-sec trial at a constant temperature, but not rate pain as intolerable during the offset 
trials.  Additionally, participants completed the Pain Catastrophizing Questionnaire and 
the Short-Form Health Survey-36 (SF-36).  A description of these questionnaires is 
provided below. 
2.3.2 Testing Sessions 
Participants were seated on a comfortable chair and relaxed for several minutes.  
Then, two blood pressure readings separated by 5 minutes were taken using a 
Datascope Accutorr Plus blood pressure monitor (Datascope Inc, Mahwah NJ).  A third 
blood pressure measurement was taken if there was a change of greater than 5% in the 
first two readings.  During the session, subjects completed an ascending/descending 
series, trials of offset analgesia, and temporal summation using thermal stimuli.   
This paper presents data from a series of seven 40-sec trials.  This includes a 
total of 4 offset trials with 2 trials increasing the baseline temperature +1.0oC and two 
trials increasing the baseline temperature +0.4oC, using a 10-sec baseline temperature 
(S1), 10-sec offset temperature (S2), and returning to the baseline temperature for the 
final 20-second paradigm (S3).  Figure 1 shows the offset sequence.  Three control 
trials were also administered in which the temperature remained constant for the entire 
40-sec trial.  All sets of trials began with a control trial.  This was followed by series A: 
+0.4oC, control, +1.0oC and series B: +1.0oC, control, +0.4oC, or the reverse BA.  The 
initial side of administration (R – L or L - R) and series order (A – B or B – A) were 
counterbalanced.  All trials were administered to the volar forearm and separated by a 
3-minute rest with the thermode position adjusted to minimize overlap. 
 
2.4 Questionnaires 
Pain Catastrophizing Scale (PCS).  The Pain Catastrophizing Scale consists of 
13 items rated on a 5-point likert scale.34  The PCS asks the respondents to reflect upon 
past painful experiences and to rate the degree to which they experienced negative 
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thoughts or feelings about pain.  The PCS measures three dimensions of 
catastrophizing: rumination, helplessness, and magnification that sum to a total score in 
which higher scores indicate greater pain catastrophizing.   
Short-Form Health Survey-36 (SF-36).  The SF-36 is a health survey that yields 
8-scale scores including: physical functioning, role limitations due to physical problems, 
bodily pain, vitality, general health perceptions, social functioning, role limitations due to 
emotional problems, and mental health.39  For the Bodily Pain Scale a higher score 
indicates less bodily pain. 
 
2.5 Data Reduction and Analyses 
SF-36 Bodily Pain score, individualized test temperatures for the offset analgesia 
trials, and the magnitude of offset analgesia for the control trials were analyzed with a 
two-way ANOVA with age and sex as between-subject factors.  Thermode temperature 
was added as a covariate for the control trial analysis. 
2.5.1. Did the magnitude of the offset temperature evoke a disproportionate increase or 
decrease in pain intensity? 
We wanted to determine whether the temperature decrease from S2 to S3 
produced greater changes in pain intensity ratings than the temperature increase from 
S1 to S2 and whether these changes differed by the magnitude in change on the offset 
temperature.  Inspection of the data indicated 1) peak pain during S1 was experienced 
at 10-sec, 2) peak pain during S2 was experienced at 20 and 21-sec (at the end of S2) 
and 3) maximum offset analgesia was experienced during the interval 33-35-sec (S3).  
Thus, maximum S1 pain rating was taken from the ratings at 10-sec.  Pain ratings at 
seconds 20-21 and 33-35 were averaged to create maximum S2 pain rating value and a 
minimum S3 pain rating value respectively.  The absolute magnitude of change in pain 
intensity ratings was calculated from S1 to S2 and from S2 to S3 (offset).  The 
dependent variables were collapsed across the two trials for each condition (+0.4oC, 
+1.0oC).  They were analyzed with a 2-way repeated measures ANOVA, with 
temperature change (0.4oC , 1.0oC) and transition (S1S2, S2S3) as the within subject 
factors.  Thermode temperature, age group and sex were included as a covariate.  
Page 8 of 24
 Temporal inhibition and aging 
Page 9 
 
2.5.2 Did the magnitude of the S1S2 increase of pain differ between age groups and 
sex? 
Next, we tested for age and sex differences in the magnitude of the S1S2 
increase in pain.  This was important to determine whether differences in offset 
analgesia is not only due to a loss in temporal inhibition, but differences in the S1S2 
increase in pain.  To accomplish this, we performed a 3 (Age: young, middle, older) × 2 
(Sex) × 2 (Condition: +0.4oC, +1.0oC) ANOVA with repeated measures on Condition.  
Thermode temperature was included as a covariate.   
2.5.3 Did the magnitude of offset analgesia differ between age groups and sex? 
To quantify the magnitude of offset analgesia, we calculated the relative 
magnitude of decrease in perceived pain following the temperature decrease. Thus, the 
magnitude of offset analgesia was calculated as the percent change from the S2 max 
pain rating with the following formula: the difference between maximum S2 and 
minimum S3 (ΔeVAS), corrected for the value of the peak eVAS during S2 [ΔeVASC= 
(ΔeVAS/maxS2)*100].  Consequently, this measures represents the percentage 
reduction in pain achieved from the offset sequence.  The magnitude of offset analgesia 
was averaged across trials for each condition (control, +0.4oC +1.0oC).  Offset analgesia 
magnitude for the experimental trials was analyzed using a 3 (Age: young, middle, 
older) × 2 (Sex) × 2 (Condition: +0.4oC, +1.0oC) ANOVA with repeated measures on 
Condition.  This model also included the Bodily Pain Scale score, Pain Catastrophizing 
score, thermode temperature, and offset magnitude from the control trials as covariates.  
Post-hoc comparisons were made with Tukey’s HSD procedure.  
2.5.4 Did magnitude of offset analgesia predict self-reported bodily pain? 
Finally, linear regression was also conducted to determine whether magnitude of 
offset analgesia predicted Bodily Pain Scale score on the SF-36, after controlling for 
age, sex, and pain catastrophizing.  Separate analyses were performed for offset of 
+0.4oC and +1.0oC because of multicollinearity.  The control variables were entered in a 
first step with forced entry method followed by the offset variable in the second step.  
The F to change statistic for step two was used to test for statistical significance.  
 
3.0 RESULTS 
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3.1 SF-36 Bodily Pain Score scale 
 The 2-way ANOVA revealed a significant effect of age group [F(2,183) = 8.677, p 
<.001], in which the younger adults (87.8±2.0) reported significantly less pain compared 
to the middle-aged adults (75.1±3.0) and older adults (76.4±2.6).  No differences 
existed between the middle-aged and older adults. 
 
3.2 Individualized Test Temperature 
 The 2-way ANOVA revealed a significant effect of sex [F(2,183) = 10.457, p 
=.001] with a higher thermode temperature was used for males (46.5±0.1oC) compared 
to females (45.9±0.1oC).  No differences were observed between age groups (18-39, 
46.1±0.1oC; 40-59, 46.0±0.2oC; 60-80, 46.4±0.3oC). 
 
3.3 Magnitude of Offset Analgesia in the Control Trials 
The two-way ANOVA conducted on the control trials did not show any significant 
effects of age, sex or an age by sex interaction on the magnitude of offset analgesia. 
Table 1 shows the magnitude of offset analgesia for the control trials for each age 
group. 
 
3.4. Did the magnitude of the offset temperature evoke a disproportionate 
increase or decrease in pain intensity? 
Figure 2 shows the average real-time eVAS pain ratings for each condition for 
younger (2A), middle-aged (2B), and older adults (2C).  The 2-Way repeated measures 
ANOVA revealed a significant effect of transition change [F(1,185) = 6.210, p = .014] 
indicating that the change in pain ratings in the S2S3 offset sequence (27.2±1.3) were 
significantly greater than during the S1S2 sequence (21.3±0.9).  The temperature by 
transition interaction was not significant indicating that the proportion of change in offset 
compared to the S1S2 increase was not different between 0.4oC. 
 
3.5 Did the magnitude of S1S2 increase associated pain differ between age 
groups and sex? 
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The three-way ANOVA revealed the expected significant main effect of condition 
[F(1,182) = 150.019, p < .001] with a greater increase for the +1.0Co trials (28.1±1.4) 
compared to the +0.4Co trials (15.7±1.1).  However, non-significant main effects were 
observed for age (p = .208) and sex (p = .269).  The 2-way age x condition interaction 
approached significance [F(2,182) = 2.529, p = .083] and supports the use of relative 
magnitude of decrease in perceived pain as the primary offset variable as it adjusts for 
differences at S2. 
 
3.6 Did the magnitude of offset analgesia differ between age groups and sex? 
 The three-way ANOVA revealed a main effect of condition [F(1,179) = 10.603, 
p=.001] and age group [F(2,179) = 6.338, p=.002].  As expected, a greater magnitude of 
offset analgesia was observed during the +1.0Co trials (53.6%±2.2) compared to the 
+0.4Co trials (39.7%±2.2).  In regards to the age differences, younger adults 
(53.8%±2.8) exhibited significantly greater offset analgesia compared to the middle-
aged (43.5%±3.9) and older adults (37.5%±3.3).  The main effect of sex and the 
interaction effects were not significant. 
 
3.7 Did magnitude of offset analgesia predict self-reported bodily pain? 
Regression coefficients for both models testing for associations between offset 
analgesia and SF-36 Bodily Pain scores are presented in Table 2.  In step one (the 
same for both offset +0.4oC and +1.0oC analyses), Age (p < .001) and PCS total scores 
(p = .012) were significantly associated greater SF-36 Bodily Pain scores.  In the final 
step for offset at +0.4oC, Age (p < .001) and  PCS total score (p = .012) remained 
significant but the variable representing offset analgesia at +0.4oC was not (p = .124).  
The F to change was 2.389, p = .124.  In the final step for offset at +1.0oC, Age (p = 
.003), PCS total score (p = .007) and the variable representing offset analgesia at 
+1.0oC (p = .002) were significant and resulted in a significant F to change of 7.809, p = 
.002.   
 
4.0 DISCUSSION 
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 Several key findings emerged from this study.  First, we showed for the first time 
that a temperature decrease as small as 0.4oC evokes a disproportionate decrease in 
pain intensity ratings (i.e., offset analgesia).  Second, the magnitude of offset analgesia 
in 0.4oC and 1.0oC trials was reduced in middle-aged and older adults compared to 
younger adults.  Third, sex differences in offset analgesia were not evident in any age 
group.  Fourth, offset analgesia in the 1.0oC trials predicted self-reported bodily pain, 
suggesting that dysfunction of this inhibitory system may be related to the experience of 
clinical pain.  
 
4.1 Age differences in offset analgesia 
 As hypothesized, older adults exhibited a reduced magnitude of offset analgesia 
compared to younger adults.  Similar to our initial study examining age differences in 
offset, older adults did not show a disproportionate decrease in pain intensity ratings 
following the slight decrease in noxious temperatures.20  Importantly, we also showed 
for the first time that offset analgesia begins to decrease in middle-age.  During the 
1.0oC trials, the younger group’s pain intensity ratings descended approximately 63% 
from period S2 to S3, while the middle age group’s pain ratings fell on average 50% and 
the older adult group’s pain ratings decreased only 44%.  Thus, the data suggest a 
gradual decline in offset analgesia across the lifespan.  Most aging and pain modulation 
studies have focused on comparisons between the younger and older cohorts, providing 
little evidence for the functioning of the pain inhibitory systems in middle-age.  In one of 
the few studies addressing the middle-age cohort, Lariviere and colleagues showed that 
pain inhibitory function measured with conditioned pain modulation also begins to 
decline in middle age.15  Therefore, the collective data suggests that the functioning of 
multiple endogenous inhibitory systems begin to deteriorate as early as middle-age, 
potentially placing middle-aged and older adults at a greater risk for developing 
persistent pain. 
 Studies examining the mechanisms underlying offset analgesia indicate that it 
involves more brain derived pain modulation compared to CPM, including a change in 
activation in the brain stem, cerebellum, and multiple cortical and subcortical 
regions.6,19,22,42  Indeed, several studies show that offset analgesia produces increased 
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activity in the dorsolateral prefrontal cortex (DLPFC) and anterior insula, which mirrors 
the activity of brain regions activated in the modulation of pain by cognitive processes 
such as placebo, distraction, and meditation.  Thus, Nahman-Averbuch and colleagues 
hypothesized that part of offset analgesia is mediated or amplified by cognitive 
processes associated to the prediction of the time course of pain.19  Additional research 
suggests an integral role of the cerebellum in offset analgesia.11  In particular, 
Ruscheweyh et al. discovered reduced offset analgesia in patients with cerebellar 
infarction compared to sex- and age- matched controls.32  Notably, normal aging is 
characterized by reduced integrity and white and grey matter volumes in the 
cerebellum3 and in cortical regions thought to play a role in the cognitive aspects of 
offset, including the insular and prefrontal cortex.1,35,36  Therefore, age-related brain 
atrophy could be one mechanism contributing to declining offset analgesia with age.  
However, it is also possible that pain-associated gray matter atrophy (versus age-
associated atrophy) could account for these differences, given the association of offset 
with bodily pain in the present study. 
 Prior research also suggests that peripheral mechanisms may be involved in the 
initiation of offset analgesia.  Naugle et al. discovered that offset analgesia occurs at the 
non-glabrous (“hairy”) skin of the forearm, but is absent in the glabrous skin of the 
palm.20  These data suggest that myelinated A-fiber mechano-heat Type II nociceptors 
(AMH-II), which are present in the non-glabrous skin35,36 but appear to be absent in the 
glabrous skin4,36, may be involved in the initiation of offset.  Animal and human research 
indicate a selective loss of myelinated afferents25,26,38 and diminished function of the 
remaining A-fibers with age.14,38  Therefore, the diminished input of AMH-II fibers in 
older adults could be another mechanism underlying reduced offset analgesia in these 
individuals.  Clearly, the proposed explanations are speculative and future research is 
needed to investigate the mechanisms causing an age-related decline in offset 
analgesia. 
 
4.2. Sex differences in offset analgesia 
 Few aging studies examining endogenous pain modulation have examined or 
been sufficiently powered to detect sex differences.  A recent meta-analysis on sex 
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differences in pain inhibitory capacity on the CPM test revealed that men show greater 
pain inhibition compared to women.28  However, no evidence exists for sex differences 
in CPM in older adults.  The evidence regarding sex differences in offset analgesia are 
mixed.  Niesters and colleagues reported greater magnitude of offset analgesia in men 
compared to women in adults aged 20-80 years old.23   However, the sex differences 
were small and likely clinically insignificant.  Naugle et al. did not show sex differences 
in offset analgesia among young or older adults4; however, that study was not powered 
to detect an age by sex interaction.  Consistent with our earlier study,20 the current 
results suggest that sex differences in offset analgesia do not exist across the lifespan.  
 
4.3. Prediction of clinical pain 
 Several studies have shown that offset analgesia is reduced in neuropathic pain 
patients23,24 and fibromyalgia patients.27   However, data demonstrating the relevance of 
offset analgesia for the experience of clinical pain is extremely limited.  To the best of 
our knowledge, the current study provided the first evidence showing that the magnitude 
of offset analgesia predicts the experience of clinical pain in adults.  Even after 
controlling for age and pain catastrophizing scores, adults who exhibited reduced offset 
analgesia reported greater bodily pain on the SF-36 Bodily Pain subscale.  Notably, the 
association between magnitude of offset and bodily pain was only evidenced with the 
1.0oC trials and not the 0.4oC trials.  Bodily pain as measured is the aggregate of many 
acute and chronic pain experiences.  Our demonstration of a link between reduced 
offset analgesia and pain in daily life supports the notion that pain modulatory deficits 
are associated with not just a chronic pain condition but with the experience of pain in 
general.  The cross-sectional nature of this study renders it possible that greater bodily 
pain leads to reduced offset analgesia.  Future research is warranted to verify the 
causal direction of the relationship between deficient offset analgesia and increased 
bodily pain in adults.  Additionally, our sample was comprised of relatively healthy adults 
and these results may not generalize to adults with chronic pain.  Nonetheless, 
accumulating evidence suggests that the capacity to activate this temporal pain 
inhibitory system plays a role in the experience of clinical pain.    
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4.4. Conclusions and Future Directions 
 In conclusion, the current study demonstrated that middle-aged and older adults 
are characterized by reduced offset analgesia.  This study is limited by its cross-
sectional nature and the inability to generalize to adults with a diagnosed chronic pain 
condition.  In addition, using an individualized temperature to ensure participants 
experienced a moderate level of pain may have created a bias where highly sensitive 
participants received less intense stimuli thermal stimulation at higher intensities which 
induces greater rostral-caudal activation on spinal cord segments.5  The use of 
intolerable pain as a maximum anchor is a potential weakness, as well as the use of 
hash marks, which may have been used as anchors creating interval rather than ratio 
scale data.  However, several strengths of this study exist.  First, we have added to the 
extremely limited data showing that pain inhibitory processes begin to decline in middle 
age.  Secondly, this study is one of the few pain modulation and aging studies that have 
been sufficiently powered to evaluate potential sex by age interactions.  Third, we 
showed for the first time that a 0.4oC decrease in temperature can elicit a 
disproportionate drop in perceived pain intensity.  Finally, the current study provides the 
first evidence of an association between bodily pain and magnitude of offset analgesia.  
 Several avenues of future research are warranted.  Research is needed to 
determine whether deficits in offset analgesia increase the risk for the development of 
chronic pain in middle-aged and older adults.  As deficient offset analgesia seems to be 
particularly characteristic of neuropathic pain patients, perhaps middle-aged and older 
adults with reduced pain inhibitory capacity on this dynamic quantitative sensory test 
are more susceptible to developing neuropathic pain conditions.  Future studies should 
also investigate whether the magnitude of offset analgesia predicts the experience of 
clinical pain in chronic pain populations.  Finally, additional research is also needed to 
determine the central and/or peripheral mechanisms that underlie the age-related 
decline in offset analgesia. 
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Figure 1.  Offset trial sequence.  At S1, a preheated thermode is applied the forearm at 
the participant’s individualized baseline testing temperature for 10 seconds.  At S2, the 
thermode is heated an additional 1.0oC or 0.4oC for 10 seconds and then cooled back to 
the baseline temperature for 20 seconds during S3.  For the control trials, the 
individualizred baseline temperature was maintained for the entire 40 second trial.  
 
Figure 2.  Average real-time eVAS rating during the +0.4oC offset trials, the 1.0oC offset 
trials, and the control trials for younger (A). middle-aged (B), and older adults (C). 
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Table 1. Magnitude (Mean ± Standard Error) of Offset Analgesia for Control, +0.4Co, 
and +1.0Co Offset Trials for Each Age Group. 
Age group Control Trials +0.4Co Trials +1.0CoTrials 
Younger Adults 9.2%±3.9 45.0%±2.9 62.6%±2.9 
Middle-age Adults 6.9%±6.0 36.9%±4.1 50.0%±4.4 
Older Adults 11.6%±4.1 31.0%±3.4 44.0%±3.7 
Total Sample 9.4%±2.6 39.7%±2.2 53.6%±2.2 
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Table 2. Regression coefficients for both models testing for associations between offset 
analgesia at +0.4oC and +0.4oC and SF-36 Bodily Pain Scale scores 
 B (SE) t p. value ∆ R2 
Step 1 (Model R2 = .11, F = (3, 184) = 6.417, p < .001)  
        Age -6.746 (1.806) -3.735 < .001  
        Sex -3.416 (2.965) -1.152 .251  
        PCS total score -.417 (.163) -2.556 .012  
   
Step 2 for +0.4oC (Model R2 = .13, F (4, 183) = 5.454, p < .001) .02 a 
        Age -6.069 (1.850 -3.280 .001  
        Sex -3.985 (2.974) -1.340 .182  
        PCS total score -.411 (.162) -2.534 .012  
        Offset +0.4oC -7.679 (4.969) -1.545 .124  
     
Step 2 for +1.0oC (Model R2 = .17, F (4, 183) = 7.045, p < .001) .06 b 
        Age -5.466 (1.802) -3.033 .003  
        Sex -3.514 (2.882) -1.219 .225  
        PCS total score -.435 (.158) -2.745 .007  
        Offset +1.0oC -11.852 (4.742) -3.132 .002  
a F to change =  2.389, p = .124 
b F to change =  7.809, p = .002 
Note: Step 1 with only covariates included is the same for both +0.4Co +1.0oC offse 
models.  Higher scores on the SF-36 Bodily Pain Scale reflect less pain.  Age was 
coded younger (18-39 years) = 1, middle-aged (40-59) = 2, and older (60-80) = 3, 
consequently the negative beta for age indicates that lower scores (greater pain) are 
associated higher coded age categories (older age).  Thermode temperature was 
included as a covariate. 
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Figure 1. 
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